Shahram Arsang-Jang
Overview
Explore the profile of Shahram Arsang-Jang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
658
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon Y, Spellman S, et al.
J Hematol Oncol
. 2025 Feb;
18(1):13.
PMID: 39894808
No abstract available.
2.
Rasouli A, Khederlou H, Milkarizi N, Arsang-Jang S, Bavandpour Karvane H, Akbarzade Z, et al.
J Tehran Heart Cent
. 2024 Dec;
19(1):38-46.
PMID: 39712355
Background: Obesity is considered a widespread concern internationally. Few studies have investigated the relationships between dairy consumption and hypertension and obesity. Therefore, this study examined the above concern in students....
3.
Dong J, Arsang-Jang S, Zhang T, Chen Z, Bolon Y, Spellman S, et al.
J Hematol Oncol
. 2024 Nov;
17(1):104.
PMID: 39497145
Mitochondrial DNA (mtDNA) variants in patients with myelodysplastic neoplasms (MDS) are shown to be prognostic of outcomes after allogeneic hematopoietic cell transplantation (allo-HCT). However, the prognostic impact of donor mtDNA...
4.
Li J, Parthasarathy A, Kannappan A, Arsang-Jang S, Dong J, Cheng C
Oncologist
. 2024 Sep;
29(11):e1552-e1564.
PMID: 39250742
In multiple myeloma (MM), while frequent mutations in driver genes are crucial for disease progression, they traditionally offer limited insights into patient prognosis. This study aims to enhance prognostic understanding...
5.
Ghanbari S, Gohari S, Reshadmanesh T, Mahjani M, Arsang-Jang S, Ismail-Beigi F, et al.
J Diabetes Metab Disord
. 2024 Jun;
23(1):1107-1111.
PMID: 38932825
Background: Sodium glucose co-transporter2 (SGLT2) inhibitors have exhibited cardioprotective properties in diabetes patients. The aim of this study was to investigate the effect of Empagliflozin on changes in echocardiographic parameters....
6.
Parham M, Tavasoli G, Arsang-Jang S, Habibi M, Dameshgi D, Pashaei M, et al.
Rev Recent Clin Trials
. 2024 Apr;
19(3):215-220.
PMID: 38561621
Aims: Iron deficiency anemia (IDA) is one of the disorders recently associated with an increase in insulin resistance (IR) and, consequently, diabetes mellitus (DM) affection by causing oxidative stress. In...
7.
Li J, Arsang-Jang S, Cheng Y, Sun F, DSouza A, Dhakal B, et al.
Blood Cancer J
. 2024 Mar;
14(1):38.
PMID: 38443358
Multiple myeloma (MM) is a heterogenous plasma cell malignancy, for which the established prognostic models exhibit limitations in capturing the full spectrum of outcome variability. Leveraging single-cell RNA-sequencing data, we...
8.
Elkoumy A, Ruck A, Abdel-Wahab M, Thiele H, Rudolph T, Wolf A, et al.
Int J Cardiol
. 2024 Jan;
400:131792.
PMID: 38244892
Background: ACURATE neo2 (Neo2) implantation is performed after systematic Balloon Aortic Valvuloplasty (BAV) in most patients. No reports exist about the feasibility and safety of direct Neo2 transcatheter aortic valve...
9.
Sabzehei F, Taromchi A, Ramazani A, Nedaei K, Feizi A, Arsang-Jang S, et al.
J Biomed Mater Res A
. 2023 Dec;
112(5):733-742.
PMID: 38088136
Among all the cancers, colorectal cancer (CRC) has the third mortality rank in both genders. Cancer vaccines have shown promising results in boosting patients' immune systems to fight cancer. Using...
10.
Taheri H, Chiti H, Reshadmanesh T, Gohari S, Jalilvand A, Arsang-Jang S, et al.
J Diabetes Metab Disord
. 2023 Nov;
22(2):1723-1730.
PMID: 37975102
Background: Empagliflozin is a sodium glucose cotransporter-2 (SGLT2) inhibitor that has been suggested to improve cardiac function and vascular recovery. The risk of coronary artery diseases is much higher in...